Oxford Immunotec Global PLC EV/Sales
Quel est le EV/Sales de Oxford Immunotec Global PLC?
Le EV/Sales de Oxford Immunotec Global PLC est 5.21
Quelle est la définition de EV/Sales?
Enterprise value to sales ratio compares a company’s total value to its sales.
ttm (trailing twelve months)
Enterprise value/sales is a valuation ratio that compares the company's enterprise value to its annual sales. It indicates the company's capacity to generate free cash flow. In general, the lower the ratio, the cheaper the company is.
EV/Sales is most often calculated as cash and cash equivalents subtracted from the sum of market capitalization and debt and divided by annual sales. Many analysts consider EV/sales to be a more accurate metric than Price/Sales as it considers both debt and equity holders in its calculation. One of the limitations of the calculation is that sales do not take into account a company's taxes or expenses.
EV/Sales des entreprises dans Health Care secteur sur NASDAQ par rapport à Oxford Immunotec Global PLC
Entreprises avec ev/sales similaire à Oxford Immunotec Global PLC
- Wave Life Sciences a EV/Sales de 5.21
- Kerry Properties a EV/Sales de 5.21
- Megaport a EV/Sales de 5.21
- Allied Esports Entertainment a EV/Sales de 5.21
- Astra Microwave Products a EV/Sales de 5.21
- Circassia Pharmaceuticals Plc a EV/Sales de 5.21
- Oxford Immunotec Global PLC a EV/Sales de 5.21
- Indiabulls Integrated Services a EV/Sales de 5.22
- ABB India a EV/Sales de 5.22
- ReTo Eco-Solutions Inc a EV/Sales de 5.22
- BlackLine Inc a EV/Sales de 5.22
- Linde Plc a EV/Sales de 5.23
- AstraZeneca Plc a EV/Sales de 5.23